Cellular biomedicine group, inc. (CBMG)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Assets
Cash and cash equivalents

-

-

-

-

-

52,812

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash and cash equivalents

21,597

15,443

29,035

39,713

45,037

-

57,925

24,785

45,555

21,568

16,292

27,298

33,361

39,252

44,115

47,470

15,667

14,884

20,106

23,651

31,144

14,770

9,815

13,563

5,957

7,175

3,465

2,060

4,857

4,144

0

61

315

602

0

34

49

Restricted cash

0

17,000

17,000

17,000

17,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term investment

-

-

-

-

-

-

10,000

10,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable, less allowance for doubtful amounts of nil and $94,868 as of December 31, 2019 and December 31, 2018, respectively

-

-

0

0

0

0

37

133

128

202

145

91

79

39

53

330

582

630

410

445

339

141

175

24

34

10

0

0

0

20

-

-

-

-

-

-

-

Other receivables

253

750

591

440

263

101

249

150

937

170

935

1,014

813

412

264

245

316

271

319

453

190

135

163

63

150

78

149

166

140

128

-

-

-

-

-

-

-

Inventory

-

-

-

-

-

-

-

-

-

-

-

-

-

-

253

313

486

390

422

400

277

372

347

156

133

119

39

30

38

37

-

-

-

-

-

-

-

Prepaid expenses

1,707

835

1,589

2,262

2,733

1,692

2,132

2,409

2,033

1,852

1,696

995

1,071

986

661

811

644

367

439

551

641

565

510

437

177

56

43

173

81

18

-

-

-

-

-

-

-

Taxes recoverable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

150

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

110

111

-

131

134

126

50

50

0

50

56

50

-

12

25

-

Total current assets

23,558

34,029

48,216

59,417

65,034

54,607

70,345

37,478

48,656

23,794

19,068

29,399

35,325

40,692

45,348

49,171

17,697

16,694

21,698

25,501

32,595

16,095

11,125

14,244

6,585

7,575

3,825

2,480

5,167

4,349

50

118

365

602

13

59

49

Investments

0

240

240

240

240

240

240

240

269

269

269

269

509

509

509

11,211

26,309

5,379

13,299

14,819

4,187

6,886

9,218

10,224

6,184

5,105

3,899

1,212

1,335

0

6,686

959

959

1,042

1,215

1,659

1,614

Property, plant and equipment, net

21,338

21,434

19,856

19,992

15,157

15,193

14,313

14,072

14,600

12,973

11,045

7,043

4,449

4,117

3,119

3,204

2,743

2,768

1,726

1,322

1,382

1,280

1,295

819

895

1,014

1,118

1,144

1,230

1,326

-

-

-

-

-

-

-

Right of use

-

-

-

-

-

15,938

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Right of use

19,280

20,106

14,298

15,203

16,017

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

7,678

7,678

7,678

7,678

7,678

7,678

7,678

7,678

7,678

7,678

7,678

7,678

7,678

7,678

7,678

7,678

7,678

7,678

7,678

7,678

7,678

7,678

7,678

0

3,299

3,299

6,808

6,808

6,808

0

-

-

-

-

-

-

-

Intangibles, net

7,035

7,376

7,521

7,868

8,259

7,970

8,153

11,538

12,029

12,419

12,844

13,260

13,677

14,092

14,570

15,018

15,511

15,949

16,323

16,817

10,868

11,156

11,715

419

506

601

687

781

857

940

-

-

-

-

-

-

-

Long-term prepaid expenses and other assets

6,997

6,458

7,640

7,286

8,951

5,952

5,683

4,805

3,491

4,026

2,720

2,226

1,949

1,537

1,507

1,256

1,360

989

1,150

915

1,226

587

541

498

300

0

161

-

-

134

-

-

-

-

-

-

-

Long-term prepaid expenses and other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

130

-

-

-

-

-

-

-

-

Long-term prepaid expenses and other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

134

-

-

-

-

-

-

-

-

-

Total assets

85,888

97,324

105,452

117,687

121,339

107,581

106,414

75,814

86,726

61,162

53,626

59,877

63,590

68,628

72,734

87,540

71,302

49,460

61,876

67,054

57,938

43,685

41,574

26,207

17,771

17,596

16,501

12,562

15,529

6,751

6,736

1,077

1,324

1,645

1,228

1,719

1,663

Liabilities and Stockholders' Equity
Liabilities:
Short-term debt

14,000

14,334

14,138

14,546

6,131

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Bank overdraft

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

41

-

-

-

-

-

-

Accounts payable

1,620

2,039

5,686

1,351

868

422

483

387

331

225

1,236

1,169

782

216

220

136

208

260

146

106

160

426

224

109

177

213

157

156

115

23

212

131

59

189

141

308

298

Disputed accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

199

202

208

208

208

208

213

Accrued expenses

2,372

1,904

1,477

1,058

1,894

1,878

1,456

1,078

1,855

1,097

728

592

325

1,168

663

457

902

845

2,574

2,927

2,216

2,074

1,862

1,071

286

503

864

1,498

2,171

97

1,165

1,070

1,067

982

879

774

542

Taxes payable

30

26

28

28

28

28

28

28

31

28

28

28

31

28

30

30

32

0

615

640

588

814

-

-

-

1,164

459

-

-

-

-

-

-

-

-

-

-

Deferred income

-

-

-

-

-

-

-

-

-

-

510

1,069

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Tax payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

10

-

-

-

-

-

-

-

-

Line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

18

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

158

251

251

-

2,866

251

396

376

366

334

334

Advances payable to related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

36

34

34

34

67

30

31

31

0

35

8

24

115

54

187

44

Other current liabilities

5,509

5,367

4,526

5,186

5,762

5,710

3,960

3,300

2,986

2,324

1,357

1,660

866

950

1,015

1,574

2,026

1,913

1,382

1,543

2,066

724

2,773

1,305

1,320

251

214

330

362

473

33

133

133

100

100

143

153

Total current liabilities

23,532

23,672

25,856

22,171

14,686

8,041

5,930

4,795

5,205

3,676

3,862

4,520

2,005

2,364

1,929

2,198

3,169

3,019

4,719

5,217

5,031

4,076

4,895

2,520

1,819

2,201

1,886

2,278

2,942

595

4,553

1,798

1,889

1,970

1,749

1,957

1,605

Other non-current liabilities

-

-

-

-

-

14,321

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

288

3,385

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-current liabilities

17,204

17,933

12,545

13,338

14,141

-

441

87

198

183

0

0

362

370

10

25

26

76

231

240

239

452

422

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability non-current

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

76

76

-

-

-

-

-

-

-

-

Total liabilities

40,737

41,606

38,402

35,510

28,828

22,362

6,371

4,883

5,404

3,859

3,862

4,520

2,367

2,734

1,939

2,512

6,581

3,095

4,950

5,458

5,271

4,529

5,317

2,520

1,819

2,201

1,886

2,355

3,019

595

4,553

1,798

1,889

1,970

1,749

1,957

1,605

Commitments and Contingencies (note 12)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

-

0

0

0

0

0

0

-

-

-

0

-

-

-

-

-

0

0

0

-

-

0

Stockholders' equity:
Preferred stock, par value $.001, 50,000,000 shares authorized; none issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

0

0

-

-

-

-

-

-

-

Preferred stock series A, no par value, 50,000,000 shares authorized; none issued and outstanding as of December 31, 2011 and 2010, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

Preferred stock series B, no par value, 50,000,000 shares authorized; none issued and outstanding as of December 31, 2011 and 2010, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

Common stock, par value $.001, 300,000,000 shares authorized; 20,427,185 and 20,359,889 issued; and 19,371,686 and 19,304,390 outstanding, as of March 31, 2020 and December 31, 2019, respectively

20

20

20

20

20

19

19

17

17

15

14

14

14

14

14

14

12

11

11

11

11

10

9

9

7

7

6

5

5

3

-

-

-

6,190

-

-

5,672

Treasury stock at cost; 1,055,499 shares of common stock as of March 31, 2020 and December 31, 2019, respectively

14,992

14,992

14,992

14,992

14,992

13,953

6,513

6,513

4,693

3,977

2,443

1,357

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock, no par value, 300,000,000 shares authorized;1,568,920 and 1,545,902 issued and outstanding as of December 31, 2012 and December 31, 2011, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,323

6,311

6,295

-

6,154

5,999

-

Additional paid in capital

273,535

272,117

271,074

270,033

267,875

250,604

249,527

206,839

205,102

172,691

157,026

155,623

153,980

152,543

150,874

148,830

109,940

103,807

101,312

99,095

95,814

75,467

66,157

49,757

39,398

37,861

31,398

26,197

25,917

14,710

-

-

-

-

-

-

-

Accumulated deficit

-211,514

-199,966

-187,279

-171,415

-159,319

-149,982

-141,463

-128,719

-119,533

-111,036

-104,114

-97,912

-91,708

-85,546

-79,406

-68,745

-61,548

-57,338

-52,346

-47,204

-42,177

-37,890

-32,360

-29,536

-22,862

-22,415

-15,962

-15,355

-12,850

-8,618

-4,095

-7,008

-6,837

-6,342

-6,641

-6,282

-5,613

Accumulated other comprehensive loss

-1,897

-1,460

-1,772

-1,468

-1,073

-1,469

-1,526

-691

428

-389

-718

-1,010

-1,063

-1,116

-687

4,929

16,316

-116

7,948

9,693

-980

1,568

2,449

3,456

-591

-57

-827

-640

-562

61

-45

-22

-22

-172

-34

45

0

Total stockholders' equity

45,151

55,717

67,050

82,177

92,511

85,218

100,043

70,931

81,322

57,302

49,764

55,357

61,223

65,893

70,794

85,027

64,720

46,364

56,925

61,596

52,667

39,156

36,256

23,686

15,952

15,395

14,614

10,206

12,510

6,156

2,183

-720

-564

-325

-521

-237

58

Total liabilities and stockholders' equity

85,888

97,324

105,452

117,687

121,339

107,581

106,414

75,814

86,726

61,162

53,626

59,877

63,590

68,628

72,734

87,540

71,302

49,460

61,876

67,054

57,938

43,685

41,574

26,207

17,771

17,596

16,501

12,562

15,529

6,751

6,736

1,077

1,324

1,645

1,228

1,719

1,663